Re: NKF meeting
|
3
|
Resverlogix Corp.
|
Mar 04, 2020 04:39PM
|
Re: Updated Van Leeuwenhoeck Institute Analyst Report and August Fact Sheet
|
3
|
Resverlogix Corp.
|
Aug 13, 2018 11:11AM
|
Re: BET bromodomain protein inhibitors and AML
|
3
|
Zenith Epigenetics
|
Aug 30, 2017 07:17AM
|
Re: No pressing business
|
3
|
Resverlogix Corp.
|
Nov 03, 2017 11:53AM
|
Re: futility
|
3
|
Resverlogix Corp.
|
Nov 07, 2016 12:12AM
|
Slide deck will be posted at commencement of live presentation
|
3
|
Resverlogix Corp.
|
Sep 12, 2018 01:58PM
|
Re: Liquidity
|
3
|
Zenith Epigenetics
|
Aug 02, 2019 03:06PM
|
BETonMACE listing on EU Clinical Trials Register
|
3
|
Resverlogix Corp.
|
Oct 19, 2015 10:51AM
|
Re: time to add/3 vs 5 pt. MACE
|
3
|
Resverlogix Corp.
|
Mar 21, 2018 12:42PM
|
DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
3
|
Resverlogix Corp.
|
Mar 28, 2019 10:42AM
|
Re: Shareholder Rights Plan
|
3
|
Resverlogix Corp.
|
Oct 18, 2017 04:59PM
|
Re: Predictions ......
|
3
|
Resverlogix Corp.
|
Nov 15, 2019 03:31PM
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Sep 13, 2018 09:13PM
|
Re: The Zenith Effect: Might It Exist?
|
3
|
Resverlogix Corp.
|
May 16, 2016 03:08PM
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 05:14PM
|
Re: Can someone post the short number up to April 30th?
|
3
|
Resverlogix Corp.
|
May 06, 2019 09:14AM
|
Re: Can we end November with a bang?
|
3
|
Resverlogix Corp.
|
Nov 30, 2018 03:14PM
|
Re: HL USA - Material or not?
|
3
|
Resverlogix Corp.
|
Apr 11, 2019 06:12PM
|
Re: Reminds me of.......
|
3
|
Resverlogix Corp.
|
Jun 25, 2019 02:24PM
|
Re: How does it work,... MACE after April 18, 2019
|
3
|
Resverlogix Corp.
|
Jul 09, 2019 09:44AM
|